These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4752629)

  • 41. Respirophonographical measurements into the effect of bromhexine in the treatment of chronic bronchitis.
    Kjer J; Christensen F; Ryskjaer S; Arseth-Hansen P
    Curr Ther Res Clin Exp; 1971 Jul; 13(7):434-43. PubMed ID: 5000296
    [No Abstract]   [Full Text] [Related]  

  • 42. [Development, tolerance and effect of Bisolvon containing suppositories for children].
    Kleinschmidt H
    Z Allgemeinmed; 1972 Jul; 48(21):977-80. PubMed ID: 5086871
    [No Abstract]   [Full Text] [Related]  

  • 43. [Children's tablets containing erythromycin and bromine hexine in comparison with dried syrup in respiratory tract infections].
    Sciuk F
    Med Welt; 1973 Mar; 24(11):418-20. PubMed ID: 4701879
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of patients presenting with Sjogren's syndrome.
    Venables PJ
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Attempts at treating rheumatoid arthritis and other chronic rheumatoid diseases with molybdenum compounds].
    Krzymień H
    Reumatologia; 1970; 8(3):193-8. PubMed ID: 5469424
    [No Abstract]   [Full Text] [Related]  

  • 46. Dry eye (Keratoconjunctivitis Sicca), rheumatoid arthritis, and Sjögren's syndrome.
    Lemp MA
    Am J Ophthalmol; 2005 Nov; 140(5):898-9. PubMed ID: 16310468
    [No Abstract]   [Full Text] [Related]  

  • 47. Sjörgren's syndrome treated with bromhexine: a randomised clinical study.
    Frost-Larsen K; Isager H; Manthorpe R
    Br Med J; 1978 Jun; 1(6127):1579-81. PubMed ID: 350346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapy of dry rhinopharyngitis].
    Raab V
    Med Monatsschr; 1973 Apr; 27(4):178-81. PubMed ID: 4709326
    [No Abstract]   [Full Text] [Related]  

  • 49. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
    Rossini G
    Med Monatsschr; 1970 Jun; 24(6):270-2. PubMed ID: 5525114
    [No Abstract]   [Full Text] [Related]  

  • 51. Alternate-day steroid therapy for patients with primary Sjögren's syndrome.
    Tabbara KF; Frayha RA
    Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708
    [No Abstract]   [Full Text] [Related]  

  • 52. Ophthalmological tests in patients with keratoconjunctivitis sicca with and without association of primary Sjögren's syndrome.
    Rivas L; Alvarez MI; Rodriguez JJ; Murube J
    Ger J Ophthalmol; 1995 Sep; 4(5):306-10. PubMed ID: 7496343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ocular tension in keratoconjunctivitis sicca in Sjögren's syndrome].
    Iudina IuV; Malakhova LA
    Vestn Oftalmol; 1983; (5):9-11. PubMed ID: 6649266
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of bromhexine inhalation on ventilation disorders following bronchography as determined through lung-perfusion scintigraphy].
    Dold U; Feine U; Schoene J; Zysno EA
    Munch Med Wochenschr; 1972 Dec; 114(50):2175-9. PubMed ID: 4678737
    [No Abstract]   [Full Text] [Related]  

  • 55. sjögren's syndrome: a correlation between ocular findings and labial salivary gland histology.
    Tabbara KF; Ostler HB; Daniels TE; Sylvester RA; Greenspan JS; Talal N
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(3):OP467-78. PubMed ID: 4837462
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cyclophosphamide-responsive subclinical Sjögren's syndrome in a patient with initial peripheral and central nervous system involvement].
    Yamanishi Y; Taooka Y; Mukuzono H; Aoi K; Ishibe Y; Yamana S
    Ryumachi; 1994 Jun; 34(3):633-8. PubMed ID: 8052929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary Sjögren's syndrome and keratoconjunctivitis sicca: diagnostic methods, frequency and social disease aspects.
    Bjerrum KB
    Acta Ophthalmol Scand Suppl; 2000; (231):1-37. PubMed ID: 11763500
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].
    Takaya M; Ichikawa Y; Yamada C; Hoshina Y; Horiki T; Uchiyama M
    Ryumachi; 1997 Jun; 37(3):453-7. PubMed ID: 9256028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Symptoms and clinical course of keratitis filiformis with special regard to Sjogren's syndrome].
    Gläser W; Pietruschka G
    Z Arztl Fortbild (Jena); 1971 Jul; 65(14):720-5. PubMed ID: 5164944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.